Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Paris, France
Countries of investment
  • Israel
Investment stages
  • Seed
  • Series A
Industries
  • Fintech
  • AI
  • Blockchain
  • Crypto
  • Health Tech
About
Delphi Ventures was founded over 30 years ago as one of the first venture Capital firms to focus exclusively on investing in life sciences companies. Their expertise spans advancing new technologies, particularly in drug discovery and medical devices. Delphi has a history of aiding companies in achieving market approval for new drugs and expanding therapeutic options for less invasive procedures.
Min check size
$10K
Max check size
$2M
Fund size
NPS

Investment Thesis

They leverage our passion, expertise, deep experience and network to help advance new technologies and build market leading companies. Delphi has helped several drugs achieve market approval. The firm has enabled dozens of companies to expand therapeutic access for patients who need less invasive procedures.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

BiLira (TRYB)

the first blockchain-based Turkish stablecoin

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp